Last viewed: aeri

Prices are updated after-hours

Health Technology Aeri

Aerie Pharmaceuticals, Inc.

AERI | $15.25 0.0%

|

Health Technology

(0.0% 1d) (0.0% 1m) (0.0% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (13.48% volume)
Earnings Calendar: 2023-02-23
Market Cap: $ 753,615,457
http://www.aeriepharma.com
Sec Filling | Patents | 380 employees

(US) Aerie Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye. Its products include Rhopressa, Roclatan, AR-13503, and AR-1105. The company was founded by David L. Epstein, Casey C. Kopczynski, Thomas J. van Haarlem, and Eric J. Toone on June 22, 2005 and is headquartered in Durham, NC.

eye treatment

Drugs

Rhopressa (netarsudil)
Rocklatan (netarsudil and latanoprost ophthalmic solution, 0.02%/0.005%)

add to watch list Paper trade email alert is off

Press-releases

Opthea Appoints U.S.-Based Leadership with Fred Guerard as CEO and Peter Lang as CFO
Published: 2023-10-27 (Crawled : 10:00) - globenewswire.com
OPT | News | $3.46 2.98% 2.89% 8.2K

|

Health Technology

| 114.37% | O: 1.25% H: 5.8% C: 2.47%
ceo

Optic Nerves Disorder Treatment Market Rises: North America Takes the Helm
Published: 2023-09-14 (Crawled : 00:00) - prnewswire.com
NVSEF | News | $96.0 6.88% 52K

|

Health Technology

| 15.36% | O: 1.84% H: 0.0% C: 0.0%
PFE | News 4 | $26.27 -0.19% -0.15% 23M

|

Health Technology

| -22.92% | O: 0.47% H: 0.41% C: -0.26%
NVS | News | $98.35 1.1% 0.0% 2.2M

|

Health Technology

| -2.41% | O: 0.28% H: 1.0% C: 0.76%
ABBV | News | $167.8 -1.03% -0.06% 4.1M

|

Health Technology

| 12.35% | O: 1.78% H: 1.76% C: 1.07%
america treatment market

DelveInsight Evaluates a Robust Dry Eye Disease Clinical Trial Pipeline as 60+ Influential Pharma Players to Set Foot in the Domain
Published: 2023-05-23 (Crawled : 15:00) - prnewswire.com
NVSEF | News | $96.0 6.88% 52K

|

Health Technology

| 13.64% | O: -1.22% H: 0.0% C: -0.62%
NVS | News | $98.35 1.1% 0.0% 2.2M

|

Health Technology

| -2.37% | O: 0.74% H: 0.0% C: -1.22%
GKOS | $100.93 -0.17% 0.0% 520K

|

Health Technology

| 70.2% | O: -0.71% H: 2.06% C: -1.05%
BHC | $8.56 0.35% 0.0% 2M

|

Health Technology

| -2.73% | O: -2.27% H: 4.24% C: -2.21%
ALC | $79.57 -1.47% 0.0% 850K

|

Health Technology

| -2.63% | O: -0.51% H: 0.02% C: -3.25%
ABBV | News | $167.8 -1.03% -0.06% 4.1M

|

Health Technology

| 15.8% | O: -0.31% H: 0.26% C: -1.34%
SNY | News | $46.66 -2.16% -2.21% 1.7M

|

Health Technology

| -12.7% | O: -0.01% H: 0.0% C: 0.0%
OCUL | News | $4.645 -7.1% -7.64% 3.9M

|

Health Technology

| -28.73% | O: 4.45% H: 7.65% C: 2.21%
GRFS | $6.4 -1.23% -1.25% 960K

|

Health Technology

| -29.08% | O: 0.78% H: 0.0% C: -3.74%
ALDX | $3.93 0.51% 0.51% 570K

|

Health Technology

| -59.63% | O: 0.0% H: 2.36% C: 0.61%
pharma disease pipeline set eye trial

Optic Nerve Disorder Treatment Market to Reach USD 5.3 Billion, Globally, by 2031 at 4.5% CAGR: Allied Market Research
Published: 2023-02-27 (Crawled : 07:00) - prnewswire.com
PFE | News 4 | $26.27 -0.19% -0.15% 23M

|

Health Technology

| -37.08% | O: -0.74% H: 0.7% C: -1.59%
NVS | News | $98.35 1.1% 0.0% 2.2M

|

Health Technology

| 14.87% | O: 0.64% H: 0.01% C: -0.72%
ABBV | News | $167.8 -1.03% -0.06% 4.1M

|

Health Technology

| 9.88% | O: 0.36% H: 0.97% C: 0.67%
treatment research market

Antiglaucoma Drugs Global Market Report 2023
Published: 2023-02-20 (Crawled : 18:00) - prnewswire.com
AERI | $15.25 0.0%

|

Health Technology

| Email alert Add to watchlist
JNJ | News | $148.53 -0.69% -0.14% 9.6M

|

Health Technology

| Email alert Add to watchlist
NVS | News | $98.35 1.1% 0.0% 2.2M

|

Health Technology

| Email alert Add to watchlist
PFE | News 4 | $26.27 -0.19% -0.15% 23M

|

Health Technology

| Email alert Add to watchlist
NVSEF | News | $96.0 6.88% 52K

|

Health Technology

| Email alert Add to watchlist
global report market

Alcon Completes Acquisition of Aerie Pharmaceuticals, Inc., Strengthening Company’s Ophthalmic Pharmaceutical Business
Published: 2022-11-22 (Crawled : 10:00) - biospace.com/
ALC | $79.57 -1.47% 0.0% 850K

|

Health Technology

| 20.67% | O: 1.79% H: 0.07% C: -0.33%
KALA | $6.5661 4.24% 1.1K

|

Health Technology

| 7.74% | O: 0.34% H: 0.5% C: -2.01%
acquisition

Global Glaucoma Treatment Market to Grow at 5.2% Annually Through 2027
Published: 2022-09-28 (Crawled : 19:00) - prnewswire.com
SNYNF | News | $94.25 -2.18% 480

|

Health Technology

| 23.96% | O: 0.22% H: 0.33% C: 0.33%
NVSEF | News | $96.0 6.88% 52K

|

Health Technology

| 54.88% | O: 1.87% H: 0.0% C: 0.0%
PFE | News 4 | $26.27 -0.19% -0.15% 23M

|

Health Technology

| -40.87% | O: -0.05% H: 0.47% C: -0.56%
NVS | News | $98.35 1.1% 0.0% 2.2M

|

Health Technology

| 28.87% | O: 0.17% H: 1.1% C: 0.16%
JNJ | News | $148.53 -0.69% -0.14% 9.6M

|

Health Technology

| -11.06% | O: -0.05% H: 0.41% C: -1.17%
SNY | News | $46.66 -2.16% -2.21% 1.7M

|

Health Technology

| 25.55% | O: -0.13% H: 0.0% C: 0.0%
REGN | News | $906.55 -0.09% -0.08% 370K

|

Health Technology

| 28.51% | O: -0.08% H: 0.25% C: -1.85%
AERI | $15.25 0.0%

|

Health Technology

| 0.73% | O: 0.13% H: 0.0% C: -0.13%
treatment glaucoma global market

AERIE PHARMACEUTICALS - INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Aerie Pharmaceuticals, Inc. - AERI
Published: 2022-09-27 (Crawled : 19:00) - prnewswire.com
ALC | $79.57 -1.47% 0.0% 850K

|

Health Technology

| 38.07% | O: -1.04% H: 2.02% C: 1.61%
AERI | $15.25 0.0%

|

Health Technology

| 0.66% | O: 0.0% H: 0.2% C: -0.07%
pharmaceuticals alert

EQUITY ALERT: The M&A Class Action Firm Launches Merger Inquiry - VIVO, AERI, CYBE, GMTX
Published: 2022-09-24 (Crawled : 20:20) - prnewswire.com
AERI | $15.25 0.0%

|

Health Technology

| Email alert Add to watchlist
ALC | $79.57 -1.47% 0.0% 850K

|

Health Technology

| Email alert Add to watchlist

Aerie Pharmaceuticals to Host Key Opinion Leader Event on Dry Eye Disease: Current Landscape, Unmet Needs, and Emerging Treatment Options
Published: 2022-09-13 (Crawled : 13:00) - biospace.com/
AERI | $15.25 0.0%

|

Health Technology

| 0.73% | O: 0.0% H: 0.4% C: 0.13%
treatment eye

See all

Last 15 days Sec forms

File Id	Form	Published Date	Transaction Date	Direction	Code	Amount Transacted	Owned Amount
0001209191-22-058191	4	2022-11-21	2022-11-21	Sell	D	7800	0
0001209191-22-058191	4	2022-11-21	2022-11-21	Sell	D	16095	0
0001209191-22-058189	4	2022-11-21	2022-11-21	Sell	D	7800	0
0001209191-22-058189	4	2022-11-21	2022-11-21	Sell	D	41984	0
0001209191-22-058188	4	2022-11-21	2022-11-21	Sell	D	16854	0
0001209191-22-058188	4	2022-11-21	2022-11-21	Sell	D	7995	0

Your Today's Watch List

Sign in to create a watchlist

Gainers vs Losers

62%

38%

Top 10 Gainers

CSSE 4 | $0.4323 183.85% 64.77% 220M

|

Consumer Services

BOF | $1.99 70.09% 41.21% 110M

|

ILAG | $0.51 6.03% 40.62% 1.7M

|

LICN | $0.941 68.04% 40.49% 15M

|

AMST | $3.31 65.5% 39.58% 70M

|

Technology Services

MTC | $3.615 61.38% 38.04% 9.3M

|

Technology Services

WIMI | $1.15 58.53% 36.92% 19M

|

Technology Services

AIH | $0.45 12.5% 30.92% 320K

|

Health Services

MULN | News | $3.78 38.46% 27.78% 13M

|

RILY | $29.86 37.48% 27.26% 12M

|

Last 48 Hours Insiders Buying

RKT P 347 | $12.55 -0.63% 0.48% 1.7M

|

| 22:30
NWFL | News | $24.6 2.03% 1.99% 9.9K

|

| 22:00
TGEN P 10000 | $0.685 39.71% 6.6K

|

| 20:01
MNSB P 310 | $15.88 -2.93% -3.02% 46K

|

| 15:30
RMCF | $3.54 0.28% 7.1K

|

Consumer Non-Durables

| 20:10

12 months watchlist earnings calendar